Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09423-cover-kras_.jpg

June 6, 2016 Cover

Volume 94, Issue 23

After decades of failures, researchers see promise in fresh approaches to developing drugs that block cancer’s toughest target

Cover image:

Credit:

Full Article
Volume 94 | Issue 23

All Issues

Have drug hunters finally cracked KRas?

After decades of failures, researchers see promise in fresh approaches to developing drugs that block cancer’s toughest target

  • In the Land of the Rising Sun, the climate improves for high-technology start-ups

    New companies still face many hurdles, but increased government support and higher risk appetite make it a bit easier to launch a start-up in Japan

  • Polyurethane makers prepare for a phase out

    As a long-used curative for urethane elastomers faces a ban in Europe, polyurethane suppliers look at alternatives

  • Jazz Pharmaceuticals to buy Celator Pharmaceuticals

    Deal worth $1.5 billion brings promising nanoparticle-based cancer drug

ADVERTISEMENT
image name
Analytical Chemistry

Parmesan test can detect cheesy imposters

GC-MS method can determine the authenticity of Parmigiano-Reggiano cheese

ADVERTISEMENT
ADVERTISEMENT